In this report, the novelty is defining angioinhibitory effect of Nef-M1 peptide and to exploring inhibition of EMT process in CRC and BC that linked to Nef-M1 peptide /CXCR4 complex. This evidence concerns the gene S100B and colorectal carcinoma.